位置:首页 > 产品库 > Cedirogant
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Cedirogant
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Cedirogant图片
CAS NO:2055496-11-0
包装与价格:
包装价格(元)
5mg询价
10mg询价

Cedirogant (ABBV-157) 是一种具有口服活性 RORγt 反向激动剂,可用于银屑病的研究。
Cas No.2055496-11-0
别名ABBV-157
分子式C24H20Cl3F3N2O3
分子量547.78
溶解度DMSO : 250 mg/mL (456.39 mM; Need ultrasonic)
储存条件Store at -20°C
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述

Cedirogant (ABBV-157) is an orally active RORγt inverse agonist. Cedirogant can be used for psoriasis research[1][2].

The transcription factor retinoic acid-related orphan receptor gamma t (RORγt) has been identified as the master regulator of TH17 cell differentiation and IL-17/22 production and is therefore an attractive target for the treatment of inflammatory diseases. Cedirogant (ABBV-157) has the potential for chronic plaque psoriasis research[1].

[1]. Elena Campione, et al. Experimental Pharmacological Management of Psoriasis. J Exp Pharmacol. 2021 Jul 26;13:725-737.
[2]. Christian Gege. Retinoic acid-related orphan receptor gamma t (RORγt) inverse agonists/antagonists for the treatment of inflammatory diseases - where are we presently• Expert Opin Drug Discov. 2021 Jul 7;1-19.

 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024